Related Experiment Video
Updated: Jun 25, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Relapsing solitary pulmonary nodule in a patient with ulcerative colitis]
A Kraft1, M Kreuter, F J F Herth
1Pneumologie und Beatmungsmedizin, Thoraxklinik am Universitätsklinikum Heidelberg. alexandra.kraft@thoraxkliniki-heidelberg.de
Anamnesis And Clinical Findings:
A 46-year-old patient with ulcerative colitis, known since she was 27 years old, was found to have a mesenteric granulomatous necrotizing inflammation containing acid-fast bacilli ten years ago. Treatment against tuberculosis was initiated. The ulcerative colitis was treated with mesalazin and, in times of peak activity, additionally with prednisolon. During periods of chronic activity the patient received azathioprin. Six years ago a solitary pulmonary nodule (coin lesion) was detected radiologically in the inferior lobe of the left lung.
Investigations:
Laboratory investigations revealed mild inflammation (CRP 1.5 mg/dl). Computed tomography showed a solitary nodule in the left lower pulmonary lobe (diameter 27 mm). Fungi, actinomyces and mycobacteria were not found.
Treatment And Course:
The pulmonary nodule was resected. During the following years several relapses occurred. After the second relapse lobectomy was performed revealing mycobacterial DNA (not further identified). Treatment against non-tuberculous mycobacteria with clarithromycin, rifampicin and ethambutol was started for 12 months. A third relapse in the form of another solitary pulmonary node occurred one year later. But this nodule regressed spontaneously in part without any additional therapy.
Conclusion:
In this case the spontaneous regression after the third relapse may represent better control of the ulcerative colitis. An infection seems less likely retrospectively.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...